AAAAAA
Results: 1-25/54
Authors:
Svensson, J
Lall, S
Dickson, SL
Bengtsson, BA
Romer, J
Ahnfelt-Ronne, I
Ohlsson, C
Jansson, JO
Citation: J. Svensson et al., Effects of growth hormone and its secretagogues on bone, ENDOCRINE, 14(1), 2001, pp. 63-66
Authors:
Tivesten, A
Caidahl, K
Kujacic, V
Sun, XY
Hedner, T
Bengtsson, BA
Isgaard, J
Citation: A. Tivesten et al., Similar cardiovascular effects of growth hormone and insulin-like growth factor-I in rats after experimental myocardial infarction, GROWTH H I, 11(3), 2001, pp. 187-195
Authors:
Jorgensen, JOL
Orskov, H
Wass, J
Astrup, J
Bengtsson, BA
Bjerre, P
Bollerslev, J
Christiansen, E
Christiansen, JS
Colao, AM
Engstrom, BE
Erfurth, EM
Flogstad, AK
Grenback, E
Hagen, C
Hoybye, C
Landolt, AM
Laurberg, P
Schreiner, T
Weeke, J
Citation: Jol. Jorgensen et al., Treatment guidelines for acromegaly. Report from a Scandinavian workshop, GROWTH H I, 11(2), 2001, pp. 72-74
Authors:
Wuster, C
Abs, R
Bengtsson, BA
Bennmarker, H
Feldt-Rasmussen, U
Hernberg-Stahl, E
Monson, JP
Westberg, B
Wilton, P
Citation: C. Wuster et al., The infuence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineraldensity, J BONE MIN, 16(2), 2001, pp. 398-405
Authors:
Kaila, L
Bengtsson, BA
Sulcs, I
Junnilainen, J
Citation: L. Kaila et al., A revision of the Elachista regificella Sircom -complex (Lepidoptera : Elachistidae), ENTOMOL FEN, 12(3), 2001, pp. 153-168
Authors:
Attie, KM
Bengtsson, BA
Blethen, SL
Blum, W
Cameron, F
Carel, JC
Carlsson, L
Chipman, JJ
Christiansen, JS
Clayton, P
Clemmons, DR
Cohen, P
Drop, S
Fujieda, K
Ghigo, E
Hintz, RL
Ho, K
Ilondo, MM
Jasper, H
Jesussek, B
Kappelgaard, AM
Laron, Z
Lippe, BM
Malozowski, S
Mullis, PE
de Muinck-Keizer-Schrama, S
Nishi, Y
Parks, JS
Phelps, C
Ranke, M
Robinson, I
Rosenfeld, RG
Rose, S
Saenger, P
Saggese, G
Savage, M
Shalet, S
Sizonenko, PC
Strasburger, C
Tachibana, K
Tanaka, T
Thorner, MO
Wikland, KA
Zadik, Z
Citation: Km. Attie et al., Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH Research Society (Reprinted from J Clin Endocrinol Metab, vol 85, pg 3990-3993,2000), J PED END M, 14(4), 2001, pp. 377-382
Authors:
Svensson, J
Johannsson, G
Bengtsson, BA
Citation: J. Svensson et al., Body composition and quality of life as markers of the efficacy of growth hormone replacement therapy in adults, HORMONE RES, 55, 2001, pp. 55-60
Authors:
Fors, H
Bjarnason, R
Wiren, L
Albertsson-Wikland, K
Bosaeus, I
Bengtsson, BA
Johansson, G
Citation: H. Fors et al., Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents, CLIN ENDOCR, 55(5), 2001, pp. 617-624
Authors:
Erfurth, EM
Bengtsson, BA
Christiansen, JS
Bulow, B
Hagmar, L
Citation: Em. Erfurth et al., Premature mortality and hypopituitarism, LANCET, 357(9272), 2001, pp. 1972-1972
Authors:
Wiren, L
Johannsson, G
Bengtsson, BA
Citation: L. Wiren et al., A prospective investigation of quality of life and psychological well-being after the discontinuation of GH treatment in adolescent patients who had GH deficiency during childhood, J CLIN END, 86(8), 2001, pp. 3494-3498
Authors:
Christiansen, JS
Bengtsson, BA
Thorner, MO
Hintz, R
Sonksen, PH
Cohen, P
Clemmons, D
Strasburger, CJ
Carlsson, L
Tanaka, T
Robinson, I
Jorgensen, JO
Johannson, G
Clayton, PE
Cowell, CT
Malozowski, SN
Hankinson, S
Yee, D
Baxter, R
Swerdlow, A
Rosenfeld, R
Fradkin, JE
Nishi, Y
Monson, JP
van den Berghe, G
Carroll, PV
Takala, J
van der Lely, AJ
Pollak, MN
LeRoith, D
Tachibana, K
Kappelgaard, AM
Langbakke, I
Lippe, B
Wilton, P
Stein, P
Salazar, DE
Maneatis, T
Blethen, SL
Cutler, GB
Blum, WF
Svanberg, E
Gertner, JM
Shimatsu, A
Takahashi, H
Citation: Js. Christiansen et al., Critical evaluation of the safety of recombinant human growth hormone administration: Statement from the growth hormone research society, J CLIN END, 86(5), 2001, pp. 1868-1870
Authors:
Hernberg-Stahl, E
Luger, A
Abs, R
Bengtsson, BA
Feldt-Rasmussen, U
Wilton, P
Westberg, B
Monson, JP
Citation: E. Hernberg-stahl et al., Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency, J CLIN END, 86(11), 2001, pp. 5277-5281
Authors:
Gotherstrom, G
Svensson, J
Koranyi, J
Alpsten, M
Bosaeus, I
Bengtsson, BA
Johannsson, G
Citation: G. Gotherstrom et al., A prospective study of 5 years of GH replacement therapy in GH-deficient adults: Sustained effects on body composition, bone mass, and metabolic indices, J CLIN END, 86(10), 2001, pp. 4657-4665
Authors:
Koranyi, J
Svensson, J
Gotherstrom, G
Sunnerhagen, KS
Bengtsson, BA
Johannsson, G
Citation: J. Koranyi et al., Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: A comparative, prospective study, J CLIN END, 86(10), 2001, pp. 4693-4699
Authors:
Hulthen, L
Bengtsson, BA
Sunnerhagen, KS
Hallberg, L
Grimby, G
Johannsson, G
Citation: L. Hulthen et al., GH is needed for the maturation of muscle mass and strength in adolescents, J CLIN END, 86(10), 2001, pp. 4765-4770
Authors:
Isgaard, J
Bengtsson, BA
Citation: J. Isgaard et Ba. Bengtsson, Growth hormone treatment in experimental heart failure, ENDOC UPD S, 9, 2001, pp. 81-85
Authors:
Ehrnborg, C
Bengtsson, BA
Rosen, T
Citation: C. Ehrnborg et al., Growth hormone abuse, BEST PRAC R, 14(1), 2000, pp. 71-77
Authors:
Ehrnborg, C
Hakkaart-Van Roijen, L
Jonsson, B
Rutten, FFH
Bengtsson, BA
Rosen, T
Citation: C. Ehrnborg et al., Cost of illness in adult patients with hypopituitarism, PHARMACOECO, 17(6), 2000, pp. 621-628
Authors:
Johannsson, G
Svensson, J
Bengtsson, BA
Citation: G. Johannsson et al., Growth hormone and ageing, GROWTH H I, 10, 2000, pp. 25-30
Authors:
Bengtsson, BA
Citation: Ba. Bengtsson, Growth hormone deficiency and the risk of cancer, GROWTH H I, 10, 2000, pp. S34-S34
Authors:
Isgaard, J
Bengtsson, BA
Citation: J. Isgaard et Ba. Bengtsson, GH and the heart: potential therapeutic use, GROWTH H I, 10(6), 2000, pp. 295-296
Authors:
Svensson, J
Bengtsson, BA
Taskinen, MR
Wiklund, O
Johannsson, G
Citation: J. Svensson et al., A nine-month, placebo-controlled study of the effects of growth hormone treatment on lipoproteins and LDL size in abdominally obese men, GROWTH H I, 10(3), 2000, pp. 118-126
Authors:
Ljung, T
Holm, G
Friberg, P
Andersson, B
Bengtsson, BA
Svensson, J
Dallman, M
McEwen, B
Bjorntorp, P
Citation: T. Ljung et al., The activity of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system in relation to waist/hip circumference ratio in men, OBES RES, 8(7), 2000, pp. 487-495
Authors:
Landin-Wilhelmsen, K
Johansson, S
Rosengren, A
Dotevall, A
Lappas, G
Bengtsson, BA
Wilhelmsen, L
Citation: K. Landin-wilhelmsen et al., Calcaneal ultrasound measurements are determined by age and physical activity. Studies in two Swedish random population samples, J INTERN M, 247(2), 2000, pp. 269-278
Authors:
Isaksson, OGP
Ohlsson, C
Bengtsson, BA
Johannsson, G
Citation: Ogp. Isaksson et al., GH and bone - Experimental and clinical studies, ENDOCR J, 47, 2000, pp. S9-S16